Someone recently bought our

students are currently browsing our notes.


Bayer AG v Commission

[1996] Case T-41/96 R

Case summary last updated at 24/01/2020 17:50 by the Oxbridge Notes in-house law team.

Judgement for the case Bayer AG v Commission

Facts: Bayer made and marketed medical drug intended to treat heart disease. As result of differences between national health authorities of MS, prices of these drugs were different across EU, lower in France and Spain. So spain and france exported great amounts of drugs to the UK. Bayer realized this was going on, but instead of giving any instructions, what they did, was, started reducing level of supplies that they provided to Spain and France, until they only supplied them with enough to cover national markets

Held: This was real unilateral behavior. No tacit agreement

Have you seen Oxbridge Notes' best Competition Law study materials?

Our law notes have been a popular underground sensation for 10 years:

  • Written by Oxford & Cambridge prize-winning graduates
  • Includes copious academic commentary in summary form
  • Concise structure relating cases and statutes into an easy-to-remember whole
  • Covers all major cases for LLB exams
  • Satisfaction guaranteed refund policy
  • Recently updated
Competition Law Notes

Competition Law Notes >>